Former Merck V.P. Named Martek's Director of Business Development and Strategic Planning

Business Wire, Oct 21, 1997

COLUMBIA, Md.--(BUSINESS WIRE)--Oct. 21, 1997--Martek Biosciences Corporation (NASDAQ: MATK) today announced that Ivan Rubin, former Vice President of Business Planning, Development, and Research for Merck & Company, will be working with Martek as Director of Business Development and Strategic Planning. Mr. Rubin played a major role in developing the strategies to position Merck as a leader in the pharmaceutical industry. Mr. Rubin will join Jerome Keller, Martek's Senior Vice President of Sales and Marketing, and former Vice President of Merck Sales in the U.S., to commercialize Martek's nutritional products.

"I echo Jerry Keller in saying that working with Martek will be an exciting and rewarding experience," said Ivan Rubin. "Martek's products will one day be viewed as essential for the health care of both children and adults."

"Ivan Rubin and Jerry Keller have worked well together," said Henry "Pete" Linsert, Jr., Martek's Chairman and CEO. "Ivan brings considerable product development and marketing expertise to Martek. Inclusion of his strategic thinking is another step toward Martek's establishing one of the best sales, marketing and business development teams in the industry."

Martek Biosciences Corporation develops, manufactures and sells products from microalgae. The Company's products include: (1) specialty, edible oils for infant formula, nutritional supplements and foods which play a central role in the development of the eyes and central nervous system; (2) high value reagents to visualize molecular interactions for drug discovery and development; (3) new, powerful fluorescent markers for diagnostics, rapid, miniaturized screening, and gene and protein detection; and, (4) sources of new pharmaceuticals.

CONTACT: Martek Biosciences Corp., Columbia

Steve Dubin

Chief Financial Officer

or

Stephanie Diaz

Director of Finance

(410) 740-0081